Yuvraj_pawp, Author at Pharma Advancement

Drug firm Pfizer on Thursday reported a 3.10 per cent decline in net profit at Rs 46.15 crore for the...

La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

23rd July 2014

La Jolla Pharmaceutical Company LJPC -6.39% (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant...

Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP

by Yuvraj_pawp

23rd July 2014

- Investment to Foster Early Biotech Start-ups - Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged oncology pharmaceutical company, announced...

Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider

by Yuvraj_pawp

22nd July 2014

Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider. Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that...

STALLERGENES Expands Latin American Presence with Acquisition of ALERGO PHARMA S.R.L. in Argentina

by Yuvraj_pawp

22nd July 2014

STALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today...

CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

by Yuvraj_pawp

21st July 2014

CTI BioPharma Corp. (CTI) announced today that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI®...

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

by Yuvraj_pawp

17th July 2014

MPP forges first agreement with a Chinese manufacturer Desano; and with Cipla, Mylan and Micro Labs; Extends Collaborations with Aurobindo, Laurus Labs and Emcure Three days before the start...

BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies

by Yuvraj_pawp

17th July 2014

Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most...

Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII

by Yuvraj_pawp

17th July 2014

Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) approved a new 7.5 mcg/hour dosage strength of...

Helsinn Group and Chugai Pharma Marketing Enter Into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA)

by Yuvraj_pawp

17th July 2014

Under the exclusive agreement, Chugai Pharma Marketing gains rights for the marketing of palonosetron in the UK and NEPA in...

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

Advancing Asia-Pacific Healthcare & Biopharma Innovation

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

Advancing Asia-Pacific Healthcare & Biopharma Innovation

Yuvraj_pawp

Pfizer net profit falls to Rs 46 crore in Q1

La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP

Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider

STALLERGENES Expands Latin American Presence with Acquisition of ALERGO PHARMA S.R.L. in Argentina

CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies

Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII

Helsinn Group and Chugai Pharma Marketing Enter Into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA)

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password